Pectuzumab
|
WikiDoc Resources for Pectuzumab |
|
Articles |
|---|
|
Most recent articles on Pectuzumab |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Pectuzumab at Clinical Trials.gov Clinical Trials on Pectuzumab at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Pectuzumab
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Pectuzumab Discussion groups on Pectuzumab Patient Handouts on Pectuzumab Directions to Hospitals Treating Pectuzumab Risk calculators and risk factors for Pectuzumab
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Pectuzumab |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Pectuzumab is a humanized monoclonal antibody used to treat cancers of epithelial origin. It binds to interleukin-2.
Template:Humanizedmonoclonals
Template:WH
Template:WikiDoc Sources